Capital DailyCapital Daily
Finance

U.S. Healthcare Spending Just Hit $5.7 Trillion and Continues to Grow: 2 Stocks to Buy to Profit From the Trend

Good medical care will always be in high demand, which makes some healthcare stocks strong long-term picks.

U.S. Healthcare Spending Just Hit $5.7 Trillion and Continues to Grow: 2 Stocks to Buy to Profit From the Trend

Published July 7, 2026 · Category: Finance

Overview

Americans continue to spend more on healthcare. Last year, the sector reached $5.7 trillion, according to some estimates, up 7.3% from 2024. Several factors drove this surge, including higher consumption of medical products and services. Further, the sector should continue expanding over the long run, driven by breakthroughs and an aging population. Investing in companies that can ride this tailwind may be a good way to earn superior returns over the long run. Here are two excellent stocks to consider along those lines: Eli Lilly (NYSE: LLY) and Intuitive Surgical (NASDAQ: ISRG).

Image source: The Motley Fool.

Not all corners of the healthcare industry will grow at the same rate. Some should expand much faster than others. The GLP-1 drug market is one area that is currently on fire and is projected to maintain a strong momentum well into the next decade. Eli Lilly is the leader in this niche. The company's GLP-1 medicines, including the diabetes treatment Mounjaro, as well as Zepbound and Foundayo, two weight-loss drugs, are posting strong sales. Eli Lilly has been growing its revenue and earnings much faster than similarly sized peers over the past two years, thanks to its dominance in this field.

Details

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.